 |
Medication Safety Officers Society 3703 Members Strong A society of healthcare professionals dedicated to improving medication safety in healthcare organizations |
PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.
Hello,
Our institution has been observing a recent increase in hypersensitivity reactions associated with fosaprepitant. The hypersensitivity reactions have been occurring within a minutes of infusion initiation, and has occurred with patients who have previously tolerated the infusion.
Has anyone observed any similar trends at their institutions?
Thank you,
Matthew Beaulac